News archive

To bring Sweden’s presidency of the EU to a close, the government is arranging a European Life Science conference to be held at Karolinska Institutet’s Aula Medica on 26–27 June. The theme of the conference is precision medicine, and KI – along with Karolinska University Hospital – has helped to draw up the programme.

Region Stockholm has launched a new action plan for precision medicine in the region. The plan, which was devised in consultation with Karolinska Institutet and Karolinska University Hospital, will allow more patients to benefit from the research being done in the field of precision medicine.

A team of researchers at Karolinska Institutet, SciLifeLab and Karolinska University Hospital will receive a total of 14.7 million Swedish kronor from the Swedish Research Council (VR). The four-year grant is part of the council’s push to increase accessibility to research infrastructure and will involve making available new technologies for clinical studies in precision medicine.

Karolinska University Hospital and Karolinska Institutet are creating Sweden’s first innovation environment for the development of precision medicine technologies. The decision to establish a join innovation environment for healthcare, research and precision medicine technologies in Solna and Huddinge is a vital step in growing the field of precision medicine.

Karolinska Institutet (KI) has been assigned the task of hosting the national node for data-driven life science in precision medicine and diagnostics. By developing and providing support and optimal conditions, the aim is to drive research in this area forwards regionally, nationally and internationally.

EIT Health Scandinavia International has awarded SEK 23 million in research grants to support international collaboration in precision prevention in rheumatology, with almost half of the grant distributed to Karolinska Institutet and Region Stockholm. The scope of the project includes creating the conditions for the early diagnosis of risk factors for developing RA (rheumatoid arthritis) and enabling patients at risk of developing RA to manage the risk through lifestyle changes.

Karolinska Institutet and Karolinska University Hospital have strengthened collaboration within precision medicine by establishing the Precision Medicine Centre Karolinska (PMCK) and have now entered into a unique cooperation agreement.

The government is set to invest through the innovation authority Vinnova another SEK 96 million on Genomic Medicine Sweden (GMS), a national organisation led from Karolinska Institutet. Regions and universities are also putting up SEK 124 million, making a total of SEK 220 million that will make it possible to continue introducing precision medicine into Swedish healthcare.

On 8 September, the German President, H.E. Frank-Walter Steinmeier and H.M. King Carl XVI Gustaf visited Karolinska Institutet and Karolinska University Hospital.

Karolinska University Hospital, Karolinska Institutet and Region Stockholm have been working together for just under a year to increase the pace of introduction of precision medicine, which briefly means diagnostics, treatment and follow-up at the right time and adapted to the patient's individual circumstances. In this collaboration, the establishment of a virtual precision medicine centre has been a priority.